A B S T R A C T Procainamide (PA) induces the production of a number of autoantibodies in a high proportion of treated individuals and in some a syndrome closely resembling systemic lupus erythematosus. The mechanism underlying this action of PA is unclear. To examine the possibility that PA might induce autoantibody formation by altering normal immunoregulatory mechanisms, the action of this drug on an in vitro model of antibody formation in man was examined. PA was found to augment the generation of immunoglobulin-secreting cells (ISC) from human peripheral blood mononuclear cells (PBM) in response to pokeweed mitogen but had no effect on pokeweed mitogen-induced tritiated thymidine incorporation. When purified populations of B and T cells were used, PA enhanced the generation of ISC in B-cell cultures supported by untreated T cells but not by T cells treated with mitomycin C. These results indicate that PA augmented B-cell responses by inhibiting suppressor T-cell activity and not by augmenting helper T-cell or B-cell function. N-Acetyl-procainamide had no effect on the generation of ISC in this system.
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The effect of PA on concanavalin A (Con A)-induced suppressor cell activity was also examined to determine whether PA altered the generation or expression of suppressor T-cell function. PBM were cultured with 30 Aig/ ml of Con A for 48 h to generate suppressor cells. When these were co-cultured with fresh PBM, the number of ISC generated was decreased by 58.1±3.4% (mean ±SEM, n = 6). Cells that had been similarly incubated without Con A were not inhibitory. The addition of PA to the Con A-stimulated cultures inhibited the generation of suppressor cells as indicated by the fact that the response of fresh cells co-cultured with the Con A-stimulated cells was diminished by only 27 .2±4.3%. In this system too, N-acetyl-procaimamide had no effect. By contrast, adding PA only to the co-culture of Con A-
INTRODUCTION
The production of various autoantibodies indicative of a state of autoimmunity has been observed commonly in patients treated with procainamide (PA)' for cardiac arrhythmia (1) (2) (3) (4) (5) (6) . Prospective studies have revealed that PA may induce antinuclear antibodies in 50-83% of individuals, and that 12-29% of PA-treated patients develop a syndrome resembling systemic lupus erythematosus (SLE) (7) (8) (9) (10) . The development of autoimmunity induced by PA is influenced by factors that affect the serum level of this agent. These include dosage (2) , duration of administration (8) , and rate of acetylation of the parent drug (11) . Thus, individuals who are slow acetylators maintain higher serum levels of PA and develop antinuclear antibodies sooner than those who are fast acetylators (11) . Consistent with these findings is the recent observation of Kluger et al. (12) that N-acetylprocainamide (NAPA), which is deacetylated in vivo only to a very limited degree, does not cause a recurrence of symptoms in most patients who previously had developed PA-induced SLE.
The mechanism underlying the development of autoimmunity in PA-treated patients remains controversial. In sera from patients with PA-induced SLE, an- ' (15) .
To obtain T-and B-cell-enriched populations, glass nonadherent cells (NAC) were rosetted with neuraminidasetreated sheep erythrocytes (N-SRBC) (16), followed by centrifugation on diatrizoate/Ficoll cushions. The interface cells were harvested, again rosetted with N-SRBC to remove residual T cells and used as a B-cell-enriched population. The pelleted cells were treated with isotonic NH4C1, passed over a nylon wool column (17) , washed three times with Hanks' balanced salt solution (HBSS) and used as the T-cell-enriched population.
In some experiments, T cells were treated with mitomycin C (Sigma Chemical Co., St. Louis, MO) before culture (17 Assay of DNA synthesis. PBM or NAC were cultured in triplicate in microtiter plates with U-bottomed wells in identical fashion to that used for the generation of ISC. 4-6 h before harvesting, 1 pCi of tritiated thymidine ([3U]Tdr, 6.7 Ci/mM, New England, Boston, MA) was added to each well. After a total incubation of 72 h, the cells were harvested onto glass fiber filter paper using a multiple sample automated harvester (Mash II, Microbiological Associates).
[3H]Tdr incorporation was measured by liquid scintillation spectroscopy. All data are expressed as the difference in counts per minute between the means of triplicate mitogen stimulated and control cultures (Acpm). Effect of PA on T-cell regulation of mitogen-induced generation of ISC. To examine further the mechanism of PA-induced augumentation of the generation of ISC, experiments using purified T and B cells were done. B cells were supplemented either with control T cells or T cells that had been treated with mitomycin C. Since inhibition of T-cell proliferation by either irradiation or mitomycin C treatment has been shown to abbrogate suppressor cell function but permit the expression of helper cell function (17, 21, 22) , this approach permitted an examination of the possibility that PA-mediated augmentation of ISC generation resulted from a selective effect on suppressor T-cell generation. Thus, it was reasoned that if PA were to augment ISC generation in cultures containing control T cells but not those containing mitomycin Ctreated T cells, the effect could be attributed to interference with the generation of suppressor T cells. To determine whether NAPA also had an effect on T-suppressor cell function, similar experiments were carried out. As can be seen in Fig. 3 , PA but not NAPA T Cells was found to have an inhibitory effect on T-suppressor cell activity.
RESULTS
When SPA was used as a mitogen, different results were obtained. SPA is a T cell-regulated polyclonal Bcell activator that is a more potent stimulator of suppressor T cells than PWM (17) . As shown in Fig. 4 , neither PA nor NAPA affected suppressor T-cell activity stimulated by SPA. Effect of PA on the immunoglobulin (Ig) isotypes secreted in response to PWM. To determine whether the effect of PA on T-cell regulation is isotype specific, both IgG SC and IgM SC were individually enumerated in the cultures stimulated with PWM as described above. Results are shown in Fig. 5 By contrast, control cells that had been preincubated with medium alone were not suppressive. Cells that had been preincubated with Con A in the presence of PA were much less suppressive than those preincubated with Con A alone. PA had no effect on control preincubated cells.
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Supplemental T Cells (x10-4) FIGURE 4 Effect of PA or NAPA on T-cell regulation of the SPA response. Experimental system was the same as in Fig. 3 Fig. 3 . IgG SC and IgM SC were enumerated using monospecific antisera.
The effect of various concentrations of PA on the generation of Con A-induced suppressor activity was examined in three individuals (Fig. 7) . PA inhibited the generation of Con A-induced suppressor cells in a concentration-dependent manner with small but statistically significant inhibition observed with as little ,ug/ml) and with or without PA (30 ug/ml) for 48 h at 370C.
After the preincubation the cells were washed with a-methyl mannopyranoside and co-cultured with fresh PBM. After a 6-d incubation with PWM (10 ug/ml), the co-cultures were assayed for the number of ISC. as 10 Ag/ml (P < 0.01, determined by repeated measures analysis of variance and Neuman-Keuls multiple comparisons). Similar experiments were done using PBM from six different normal donors (Table II) . In these experiments the number of ISC generated in co-cultures containing three parts of fresh responding cells and one part of the putative suppressor or control preincubated cells was determined. Either PA or NAPA was added during the culture used to generate the suppressor cells. Without Con A in the first culture, no suppressor cells were generated and PA was without effect. When Con A was present during the preincubation, suppressor cells were routinely generated. The mean percent inhibition of PWM responsiveness in these six experiments was 58.1%. When PA was included in the culture used to stimulate suppressor cells, the percent suppression decreased to 27.2 (P < 0.005, determined by one-way analysis of variance and Neuman-Keuls multiple comparisons). This decrease in suppression indicates that PA has an inhibitory action on the generation of Con A-induced suppressor function. This difference could not be explained by an alternation in the viability of the cells since the cells cultured with PA were >85% viable by trypan blue staining and not different in this respect from those cultured without PA. When NAPA was included in the culture used to generate suppressor cells, no effect on suppressor cell activity was observed. In three of six experiments, autologous PBM were used as target cells in the second cultures. There was no significant difference in the Concentration of Con A, 30 ig/ml.
Concentration of PA and NAPA, 30 ,g/ml. § Values represent the mean percent decrease from predicted numbers of ISC in PWM-stimulated cultures. Six experiments are averaged. In three, the Con A-stimulated cells were homologous, in three they were autologous. 11 Values differ significantly (P < 0.005). results obtained in the autologous or homologous cocultures.
The effect of PA on the second co-culture stimulated with PWM was examined. When PA was added only to the co-culture of fresh PBM (Table III) with Con A-activated suppressor cells, mean percent suppression of ISC decreased from 62.9 to 47.7% (A = 15.2%). On the other hand, when PA was added only to the coculture of control preincubated cells with fresh PBM cells, the percent suppression of ISC decreased from 2.4 to -7.8% (A = 10.2%). Thus, the effect of adding PA only to the assay co-culture was similar in magnitude when either Con A-activated or control preincubated cells were present. These results suggest that the major action of PA when present in the assay coculture does not relate to its action on the Con A-induced suppressor cells but rather to an additional effect on the generation of suppressor cells from the responding population. They support the conclusion that the major action of PA involves inhibition of the generation of suppressor cells and not the expression of suppressor cell function.
In some experiments, Con [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] ;g/ml. Serum levels of treated patients are in this range (23) , and sometimes higher (24) , and tissue levels are generally higher (25) . Second, PA augmented both IgM and IgG ISC, and autoantibodies of both classes have been observed in PA-treated individuals (6) . A third parallel of special interest is that NAPA had no effect on suppressor function either of the PWM-generated or Con A-stimulated suppressor T-cell populations. This finding is consistent with the decreased ability of NAPA, compared with PA, to induce antinuclear antibody and anti-ssDNA antibody formation (26) and with its failure to exacerbate the lupus syndrome in patients in whom this condition had recently developed on PA (12) .
It has been proposed that the autoimmune response in patients receiving PA is stimulated by an autoantigen formed in a reaction between PA, or metabolic products of PA, and an autologous macromolecule or membrane constituent (4, 11, 13) . Such an interaction could result in a variety of autoantibodies including antinuclear antibodies specific for histones (5) and ssDNA (3, 27) , as well as rheumatoid factor (1), antierythrocyte (1) and antilymphocyte (6) autoantibodies. However, the large number of autoantibodies evoked by PA has suggested, alternatively, that this drug acts directly on the immune system to stimulate autoantibody formation (6, 12, 14, 28) . Bluestein et al. (6) observed a markedly increased frequency of coldreactive lymphocytotoxic antibodies in patients treated with PA and a rapid disappearance of this antibody following withdrawal of PA in patients with PA-induced SLE. In addition, the lymphocyte response to phytohemagglutinin in vitro was reduced at elevated concentrations of PA and enhanced at therapeutic concentrations. They proposed that antinucleic acid antibodies might appear in PA-treated patients as a consequence of a disorder of immune regulation resulting from a reaction between PA and lymphocyte membranes. In addition, this same group has reported that when PA was added to antigen-driven cultures of sheep erythrocyte-primed rabbit spleen cells, a prolonged antibody-forming cell response was observed (29) . This experiment suggested that PA acted by altering suppressor T-cell circuits that may regulate this in vitro response. The findings of our study are consistent with the hypothesis that PA interferes with normal immunoregulation through the mechanism of interfering with the generation of certain suppressor Tcell networks.
Genetic factors play a role in the autoimmune effect of PA. In patients receiving this drug, autoantibodies occur more frequently and at higher titer, and PAinduced lupus develops more rapidly in subjects who are slow acetylators (11, 26) . Moreover, an association of the development of drug-induced lupus with an HLA marker has been observed in the case of hydralazine. Batchelor et al. (30) have reported that almost all patients with hydralazine lupus were not only slow acetylators but that there also was an aggregation of the expression of the HLA-DR4 allele in this condition. Whether there is also an HLA association with PA-induced disease is not known.
Whether all drugs that have the capacity to induce the production of autoantibodies as well as SLE exert their effects by inhibition of autoregulatory T-cell function is at present unclear. Kirtland et al. (31) reported that methyldopa, which may induce the development of a variety of autoantibodies in treated patients (32) , was capable of inhibiting suppressor Tcell function in vitro. This effect was observed in isolated T cells incubated with methyldopa and in T cells from patients taking methyldopa. Other studies demonstrating a selective effect on suppressor T-cell function by SLE-inducing drugs have not been reported, although it has been suggested that autoantibody formation induced by D-penicillamine therapy may also be related to suppressor T-cell dysfunction caused by this drug (33) .
In conclusion, we have demonstrated that PA, but not its acetylated metabolite, is capable of interfering with the generation of suppressor T-cell activity in normal human peripheral blood lymphocytes following PWM and Con A stimulation. We propose that a similar immunomodulatory effect may be induced by PA in vivo leading to the production of autoantibodies in patients treated with drug (1, 2, 7, 10, 27).
